Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.
KEAP1/NRF2 介导的差异性信号传导拓宽了小细胞肺癌治疗中氧化还原靶向药物的治疗窗口。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-71608-4
Samarin Jana, Nůsková Hana, Fabrowski Piotr, Malz Mona, Amtmann Eberhard, Taeubert Minerva J, Pastor-Flores Daniel, Kazdal Daniel, Kurilov Roman, de Vries Nicole, Pink Hannelore, Deis Franziska, Hummel-Eisenbeiss Johanna, Renz Lisa, Kaushal Kamini, Morgen Michael, Dick Tobias P, Hamilton Gerhard, Muckenthaler Martina, Mall Moritz, Lim Bryce, Kanamaru Taishi, Klinke Glynis, Sos Martin L, Frede Julia, Miller Aubry K, Alborzinia Hamed, Gunkel Nikolas
